I
PFE icon

IberiaBank’s Pfizer PFE Stock Holding History

IberiaBank’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.04M Sell
98,017
-1,987
-2% -$67.5K 0.36% 84
2020
Q1 		$3.1M Sell
100,004
-2,530
-2% -$86.2K 0.41% 76
2019
Q4 		$3.81M Sell
102,534
-3,688
-3% -$131K 0.4% 77
2019
Q3 		$3.62M Sell
106,222
-7,721
-7% -$281K 0.42% 74
2019
Q2 		$4.68M Sell
113,943
-18,131
-14% -$720K 0.52% 63
2019
Q1 		$5.32M Sell
132,074
-1,049
-0.8% -$42K 0.62% 54
2018
Q4 		$5.51M Sell
133,123
-5,877
-4% -$244K 0.72% 46
2018
Q3 		$5.81M Sell
139,000
-12,656
-8% -$487K 0.73% 41
2018
Q2 		$5.22M Sell
151,656
-5,832
-4% -$199K 0.91% 33
2018
Q1 		$5.3M Sell
157,488
-22,950
-13% -$789K 1.06% 20
2017
Q4 		$6.2M Sell
180,438
-1,838
-1% -$62.7K 0.97% 26
2017
Q3 		$6.18M Buy
182,276
+14,854
+9% +$477K 1.03% 28
2017
Q2 		$5.34M Buy
167,422
+7,568
+5% +$239K 1.59% 16
2017
Q1 		$5.19M Sell
159,854
-9,933
-6% -$313K 1.63% 16
2016
Q4 		$5.23M Buy
169,787
+27,134
+19% +$828K 1.92% 14
2016
Q3 		$4.58M Buy
142,653
+7,323
+5% +$245K 1.95% 16
2016
Q2 		$4.52M Buy
135,330
+6,736
+5% +$215K 1.99% 15
2016
Q1 		$3.62M Sell
128,594
-406
-0.3% -$11.6K 1.71% 25
2015
Q4 		$3.95M Buy
129,000
+9,952
+8% +$313K 1.77% 21
2015
Q3 		$3.55M Sell
119,048
-1,032
-0.9% -$33.1K 1.82% 20
2015
Q2 		$3.82M Buy
120,080
+5,295
+5% +$173K 1.7% 20
2015
Q1 		$3.79M Buy
114,785
+28,017
+32% +$891K 1.7% 16
2014
Q4 		$2.56M Sell
86,768
-4,068
-4% -$117K 1.4% 28
2014
Q3 		$2.55M Buy
90,836
+11,820
+15% +$332K 1.43% 28
2014
Q2 		$2.23M Buy
79,016
+1,105
+1% +$31.5K 1.24% 30
2014
Q1 		$2.37M Buy
77,911
+4,087
+6% +$122K 1.46% 25
2013
Q4 		$2.15M Buy
73,824
+17,415
+31% +$507K 1.4% 27
2013
Q3 		$1.54M Buy
56,409
+9,572
+20% +$260K 1.01% 36
2013
Q2 		$1.25M Buy
+46,837
New +$1.29M 0.94% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IberiaBank's PFE Position: Q2 2020 in Review

IberiaBank reduced its Pfizer (PFE) stake by 2% in Q2 2020, selling an estimated $67.5K and leaving 98,017 shares worth $3.04M. The position accounts for 0.36% of the portfolio, ranked #84.

IberiaBank first reported a position in PFE in Q2 2013 and has held it in 29 quarters since. The position peaked at $6.2M in Q4 2017. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • IberiaBank held 98,017 shares of Pfizer worth $3.04M as of Q2 2020.
  • IberiaBank sold 1,987 Pfizer shares in Q2 2020, an estimated $67.5K.
  • Pfizer made up 0.36% of IberiaBank's portfolio in Q2 2020, its #84 holding.
  • IberiaBank first reported a position in Pfizer in Q2 2013 and has held it in 29 quarters since.
  • IberiaBank's Pfizer position peaked at $6.2M in Q4 2017.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.